Drug Development

Articles

A pilot project, beginning in 2017, will support the development of biosimilars.

EMA Launches Biosimilars Project

Univercells received a grant from the Bill & Melinda Gates Foundation for the development of a vaccine manufacturing platform.

Univercells Receives $12-Million Grant to Develop Vaccine Manufacturing Platform

Oxford Genetics received £1.61 million from Innovate UK to explore computational and synthetic biology approaches for optimized mammalian bioproduction.

Oxford Genetics Receives Grant from Innovate UK

GlaxoSmithKline opened a new vaccines R&D center in Rockville, MD creating up to 200 new jobs.

GSK Opens Global Vaccines R&D Center in Maryland

Researchers test the efficacy of a new polymer that is an alternative to PEG for drugs used to treat type 2 diabetes.

Duke Researchers Test PEG-Alternative as a New Drug Delivery Technology

Quantitative and qualitative tools allow better understanding of mixing in a single-use bioprocessing system.

Evaluating Mixing in a Single-Use Bioprocessing System

Martin KÃ¶berle, PhD, is head of Analytical Development &Stability Testing, at Hermes Pharma.

Detlev Haack, PhD, is head of Research & Development at Hermes Pharma.

Hot-melt coating was used to develop taste-masked orally disintegrating granules of acetaminophen and caffeine.

From Bitter to Sweet: Developing a User-Friendly Painkiller

Takeda will invest more than 100 million Euros to build a new manufacturing plant for its dengue vaccine candidate in Singen, Germany.

Takeda Builds Dengue Vaccine Manufacturing Plant in Germany

Oxford Genetics has been awarded a grant to develop packaging cell lines for virus bioproduction and will work in collaboration with the University of Oxford to generate cell lines for the scalable manufacture of retrovirus and lentivirus vectors.

Oxford Genetics and University of Oxford Form Virus Production Pact

Avecia is adding drug substance capacity at its Milford, MA manufacturing site.

Formulation and Drug Delivery